Alkermes reports Q2 non-GAAP EPS 70c, consensus 70c
PremiumThe FlyAlkermes reports Q2 non-GAAP EPS 70c, consensus 70c
2M ago
Is ALKS a Buy, Before Earnings?
Premium
Pre-Earnings
Is ALKS a Buy, Before Earnings?
2M ago
Alkermes price target lowered to $31 from $32 at JPMorgan
Premium
The Fly
Alkermes price target lowered to $31 from $32 at JPMorgan
2M ago
Alkermes Shareholders Approve Board Changes and Stock Plan
PremiumCompany AnnouncementsAlkermes Shareholders Approve Board Changes and Stock Plan
4M ago
Alkermes price target raised to $48 from $43 at Cantor Fitzgerald
Premium
The Fly
Alkermes price target raised to $48 from $43 at Cantor Fitzgerald
4M ago
Alkermes price target raised to $48 from $43 at Cantor Fitzgerald
Premium
The Fly
Alkermes price target raised to $48 from $43 at Cantor Fitzgerald
4M ago
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Alkermes initiates Phase 2 clinical trial of ALKS 2680
Premium
The Fly
Alkermes initiates Phase 2 clinical trial of ALKS 2680
5M ago
Alkermes price target lowered to $23 from $25 at UBS
Premium
The Fly
Alkermes price target lowered to $23 from $25 at UBS
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100